ArticleEClinicalMedicine2022

A randomised, double-blind, placebo-controlled, multicentre clinical trial of AZD1656 in diabetic patients hospitalised with COVID-19: The ARCADIA Trial - implications for therapeutic immune modulation.

Jamie Chorlton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.